Global Radiotherapy Market Worth $5.8 Billion by 2016
The global market was valued at $4.4 billion in 2011 and is expected to reach $5.8 billion by 2016, at a CAGR of 5.3% from 2011 to 2016.
Pune, Maharashtra, November 27, 2015 (Newswire.com) - The “Radiotherapy Market by Products, Technology & Applications Till 2016 - Cyberknife, Gammaknife, Linac, Tomotherapy, Cyclotron, Synchrotron, Radionuclides, Iodine-131, IMRT, IGRT, Volumetric Modulated Arc Therapy & Stereotactic Radiosurgery (2011 – 2016)”, published by MarketsandMarkets analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia, and rest of the World including Japan.
Radiotherapy is the process of treatment of affected tissue through energy emitting particles such as X-rays, gamma rays, electron beams, or protons. There is a broad array of electromagnetic waves depending upon its frequencies and wavelengths. The shorter the wavelength, the higher the destruction capacity of damaged tissues. This short wavelength damages the tissues with ionizing radiation. Radiation generates free radicals and direct ionization of oxygen molecules. These ionized molecules cause different kind of DNA damages such as double strand breakage of DNA strands. This DNA damages lead to cell death.
Get The PDF Brochure For This Report@
The radiotherapy industry is under dramatic transformation globally and would see significant changes in the coming years, primarily driven by technological innovation, globalization and rising reimbursement support in the western healthcare systems. Recent developments in radiotherapy devices and technologies have led to the emergence of new fully comprehensive systems, enabling diagnosis, treatment, and follow-up all simultaneously. Compact advanced radiotherapy devices segments of radiotherapy market show tremendous potential and performance in the coming years and represent the fastest market growth.
Compact advanced radiotherapy systems such as CyberKnife, Gamma Knife and TomoTherapy added optimum value to the radiotherapy outcome with a comprehensive system of linear accelerator and high quality imaging system. Currently, 4D IGRT and next generation IMRT and IGRT have grown largely in the radiotherapy market by providing better quality services. Volumetric Modulated Arc Therapy (V-MAT) and Adaptive Radiation Therapy are two significant evolutions among all.
Get The Sample Copy Of This Report@
Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. A considerable amount of clinical research data on the better clinical outcomes through this new therapy is driving the demand of the novel radiotherapy devices market. The U.S., Europe and Japan have been the pioneer in this medical revolution. Majorly, U.S. and Europe comprise the maximum share of this market but developing countries such as Asian countries and other regions of the world are adopting new policies to welcome this therapeutic procedure in the fight against cancer.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,